3 research outputs found
Efficacy of an imidacloprid/flumethrin collar against fleas, ticks, mites and lice on dogs
BACKGROUND: The studies reported here were conducted to ascertain the efficacy of imidacloprid/flumethrin
incorporated in a slow-release matrix collar, against infestations of dogs by fleas, ticks, mites and lice. Efficacy was
evaluated against the flea Ctenocephalides felis felis, the ticks Rhipicephalus sanguineus, Ixodes ricinus, Ixodes
scapularis, Dermacentor reticulatus and Dermacentor variabilis, the mite Sarcoptes scabiei and the biting louse
Trichodectes canis.
METHODS: Groups of collar-treated dogs (n = 7–10) were infested with fleas and/or ticks at monthly intervals at least,
over a period of up to 8 months. Efficacy against fleas was evaluated 24 to 48 h after treatment and 24 h after each
re-infestation. Efficacy against ticks was evaluated at 48 h (acaricidal), 6 h (repellent) and 48 h (sustained) after
infestation. The effect of regular shampooing or immersion in water on the efficacy of the collars was also tested.
Efficacy against flea larvae was assessed by incubating blanket samples after dog contact with viable flea eggs.
Effectiveness against lice and mites was evaluated after treatment of naturally infested animals. With the exception
of the mites, efficacy was calculated by comparison with untreated negative control groups.
RESULTS: Efficacy against fleas (24 h) generally exceeded 95%, and against flea larvae it exceeded 99% for 8 months.
Sustained acaricidal (48 h) efficacy, covering a period of 8 months was 100% against I. ricinus, starting 2 days after
treatment (in vivo), and 100% against I. scapularis (in vitro), above 97% against R. sanguineus, generally above 97%
against D. reticulatus and above 90% for D. variabilis.
Repellent (6 h) efficacy 2 days after treatment and continuing for 8 months was consistently 100% against I. ricinus,
and above 90% against R. sanguineus.
Regular shampooing affected efficacy against fleas and ticks to a lesser extent than regular immersion in water.
The collars eliminated Trichodectes canis within 2 days and Sarcoptes scabiei within 3 months.
CONCLUSION: The rapid insecticidal and acaricidal properties of the medicated collars against newly-acquired
infestations of fleas and ticks and their sustained high levels of preventive efficacy have been clearly shown.
Consequently they have the potential to prevent the transmission of vector-borne diseases and other conditions
directly associated with infestation throughout an entire season of parasite abundance.DS, EMK, JJF and WD designed the study design and protocols and JJF and
EMK carried out the studies. DS, JJF, EMK and WD and IGH compiled and
analysed the data. IGH was responsible for the first draft of the manuscript, which was then substantially revised by all authors. All authors read and
approved the final manuscript.These clinical studies were completely funded by Bayer Animal Health
GmbH, Monheim, Germany, of which D. Stanneck (Germany) and K. Krieger
are employees, and by Bayer HealthCare LLC, Animal Health (USA). ClinVet is
an independent Contract Development Organisation, which was contracted
to manage the conduct of a part of these studies. I.G. Horak is a long-term,
contract employee of Clinvet and an Honorary Professor at the Universities
of the Free State and Pretoria. The authors are sincerely grateful to all monitors, investigators and the staff
of the study locations either linked to the authors or serving as independent
CROs who took part in the numerous studies and ensured that the high GCP
and GLP standards were adhered to.http://www.parasitesandvectors.com/content/5/1/102am2013ab201
The synergistic action of imidacloprid and flumethrin and their release kinetics from collars applied for ectoparasite control in dogs and cats
<p>Abstract</p> <p>Background</p> <p>The control of tick and flea burdens in dogs and cats has become essential to the control of important and emerging vector borne diseases, some of which are zoonoses. Flea worry and flea bite hypersensitivity are additionally a significant disease entity in dogs and cats. Owner compliance in maintaining the pressure of control measures has been shown to be poor. For these reasons efforts are continuously being made to develop ectoparasiticides and application methods that are safe, effective and easy to apply for pet owners. A new polymer matrix collar has recently been developed which is registered for 8 months use in cats and dogs. The basic properties of this collar have been investigated in several <it>in vitro </it>and <it>in vivo </it>studies.</p> <p>Methods</p> <p>The effects of imidacloprid, flumethrin and the combination were evaluated in vitro by means of whole cell voltage clamp measurement experiments conducted on isolated neuron cells from <it>Spodoptera frugiperda</it>. The in vitro efficacy of the two compounds and the combination against three species of ticks and their life stages and fleas were evaluated in a dry surface glass vial assay. The kinetics of the compounds over time in the collar were evaluated by the change in mass of the collar and measurement of the surface concentrations and concentrations of the actives in the collar matrix by HPLC. Hair clipped from collar treated dogs and cats, collected at various time points, was used to assess the acaricidal efficacy of the actives ex vivo.</p> <p>Results</p> <p>An <it>in vitro </it>isolated insect nerve model demonstrated the synergistic neurotoxic effects of the pyrethroid flumethrin and the neonicotinoid imidacloprid. An <it>in vitro </it>glass vial efficacy and mortality study against various life stages of the ticks <it>Ixodes ricinus, Rhipicephalus sanguineus </it>and <it>Dermacentor reticulatus </it>and against the flea (<it>Ctenocephalides felis</it>) demonstrated that the combination of these products was highly effective against these parasites. The release kinetics of these actives from a neck collar (compounded with 10% imidacloprid and 4.5% flumethrin) was extensively studied in dogs and cats under laboratory and field conditions. Acaricidal concentrations of the actives were found to be consistently released from the collar matrix for 8 months. None of the collar studies in dogs or cats were associated with any significant collar related adverse event.</p> <p>Conclusion</p> <p>Here we demonstrated the synergism between the pyrethroid flumethrin and the neonicotinoid imidacloprid, both provided in therapeutically relevant doses by a slow release collar matrix system over 8 months. This collar is therefore a convenient and safe tool for a long-term protection against ectoparasites.</p
Efficacy of an imidacloprid/flumethrin collar against fleas and ticks on cats
BACKGROUND: The objectives of the studies listed here were to ascertain the therapeutic and sustained efficacy of
10% imidacloprid (w/w) and 4.5% flumethrin (w/w) incorporated in a slow-release matrix collar, against
laboratory-infestations of fleas and ticks on cats. Efficacy was evaluated against the flea Ctenocephalides felis felis,
and the ticks Ixodes ricinus, Amblyomma americanum and Rhipicephalus turanicus. The number of studies was so
large that only a general overview can be presented in this abstract.
METHODS: Preventive efficacy was evaluated by infesting groups of cats (n = 8-10) with C. felis felis and/or I. ricinus,
A. americanum or R. turanicus at monthly intervals at least, for a period of up to 8 months. Efficacy against fleas was
evaluated 24 to 48 h after treatment and 24 h after infestation, and against ticks at 6 h (repellent) or 48 h
(acaricidal) after infestation. Efficacy against flea larvae was evaluated over a period of 8 months by incubating
viable flea eggs on blanket samples after cat contact. In all cases efficacy was calculated by comparison with
untreated negative control groups.
RESULTS: Efficacy against fleas (24 h) generally exceeded 95% until study termination. In vitro efficacy against flea
larvae exceeded 92% until Day 90 and then declined to 67% at the conclusion of the study on Day 230.
Sustained acaricidal (48 h) efficacy over a period of eight months was consistently 100% against I. ricinus from Day
2 after treatment, 100% against A. americanum, except for 98.5% and 97.7% at two time-points, and between 94%
and 100% against R. turanicus.
From Day 2 until 8 months after treatment the repellent (6 h), efficacy was consistently 100% against I. ricinus, and
between 54.8% and 85.4% against R. turanicus.
CONCLUSION: The rapid insecticidal and acaricidal properties of the medicated collars against newly- acquired
infestations of fleas and ticks and their sustained high levels of preventive efficacy have been clearly demonstrated.
Taking into account the seasonality of fleas and ticks, the collars have the potential to prevent the transmission of
vector-borne diseases and other conditions directly associated with infestation throughout the season of parasite
abundance.Bayer Animal Health GmbH, Monheim, Germany and by Bayer HealthCare LLC, Animal Health (USA).http://www.parasitesandvectors.com/5/1/82ab2012ab2013 (Author correction